Myotonic dystrophy (DM) is associated with an underlying CTG trinucleotide repeat expansion at a locus on chromosome 19q13.3. We have determined the repeat length in 23 DM patients with varying clinical severity ofsymptoms and various sizes of repeat amplification. We confirm that as in previous studies there is no strong correlation between repeat length and clinical symptoms but find that the repeat length in peripheral blood cells of patients increases over a time span of five years indicating continuing mitotic instability of the repeat throughout life. Repeat length progression does not appear to be indicative of clinical progression but age probably is. The degree of expansion correlates with the initial repeat size and 50% of the patients with continuing expansions showed clinical progression of their disease symptoms over the five year study period.
Myotonic dystrophy (DM) is a multisystemic disorder characterised by a highly variable clinical phenotype including myotonia, progressive muscle weakness, and cataract. It is inherited as an autosomal dominant trait and is the commonest cause of adult muscular dystrophy.' All DM mutations characterised to date exhibit amplifications of a CTG trinucleotide repeat located in the 3' untranslated region of a protein kinase gene (DMPK) on chromosome 19q13.3.27 A positive correlation is seen between earlier onset/greater severity and increasing CTG repeat number. 8 The number of CTG repeats at this locus within the general population has been shown to be highly polymorphic. 9 Intergenerational expansion of the repeat length is seen in DM families and underlies the phenomenon of anticipation. '0 Little is known of the pathological processes which lead from a CTG expansion to the disease phenotype, or about the mechanisms which determine repeat size and stability. Southern analysis of DM genomic DNA samples identifies smears of heterogeneous length fragments in the DM allele and tissue variability of the repeat size in individual DM patients." The different expansion patterns seen in monozygous DM twins also seem to indicate a high degree of mitotic instability. '2 Previous investigations of the instability of the repeats with time have shown a difference in the peripheral blood lymphocytes of patients compared to their transformed lymphoblastoid cell lines after many passages. '3 In this paper we present data obtained from 23 DM patients with differing severities of phenotype and various sizes of CTG expansion. We have determined the length of the repeat in DNA of peripheral blood lymphocytes taken at intervals of five years between visits. We show that the repeat length in DM patients' blood cells is continuing to expand with time, indicating continuing mil.tic instability in this condition. We show that the degree of expansion seen in this timeframe correlates with the initial size of the repeat.
Materials and methods
Twenty three DM patients whose DNA samples were analysed for molelcular diagnosis or presymptomatic testing five years ago were recontacted and a new blood sample obtained. The patients were grouped into four different classes based on age of onset and severity of symptoms: A (asymptomatic obligate carriers), B (late onset with minimal features of the disease), C (classic adult onset), and D (early onset cases and congenitally affected). The patients were re-evaluated when they came for their repeat blood sample by the neurologist who saw them originally using the same diagnostic criteria. The clinical parameters examined included the following. were carried out in a total volume of 50 gil with 700 ng of genomic DNA. The conditions used were as described previously. '4 PCR products were resolved by electrophoresis on 3-5% Nusieve gels or 3-5%
Metaphor agarose gels or both. Repeats of >200 CTGs were analysed by Southern blotting.
DNA (5 rg) was digested with EcoRI and electrophoresed on 0-6% agarose gels, denatured in 0-5mol/l NaOH/1-5mol/l NaCl, neutralised in 0-5 mol/l Tris (pH 7-0)/1-5 mol/l NaCl and transferred onto a Hybond-N membrane in 10 x SSC. Filters were probed with cDNA254 labelled with 32p using the random priming method. 5 The CTG repeat amplification was determined at the point ofhighest band intensity using densitometric scanning of the autoradiograph.
Results
Sixteen of the 23 patients in this study were neurologically evaluated and followed clinically over the five year period by one of us (JMM). 
